创新医疗董事阮光寅减持0.10万股，成交均价11.67元

Core Insights - The article reports on the stock trading activities of the director of Innovation Medical, Ruan Guangyin, who reduced his holdings by 0.10 million shares at an average price of 11.67 yuan, resulting in a total change of 1.17 thousand yuan, leaving him with 1.9199 million shares [1] Company Overview - Innovation Medical's main business includes hospital management consulting services, industrial investment, research and development of medical devices and pharmaceutical products, management consulting for medical enterprises, and health management consulting services, excluding diagnostic services [1] - The company also engages in import and export business, subject to approval from relevant authorities [1] Financial Performance - As of December 31, 2024, the company's medical service revenue was 812 million yuan, accounting for 99.52% of total revenue, while other supplementary income was 3.8785 million yuan, making up 0.48% [1] Shareholder Activity - Recent shareholding changes include: - Ruan Guangyin sold 1,000 shares on June 10, 2025, at an average price of 11.67 yuan, reducing his holdings to 1.9199 million shares [1] - On May 30, 2025, he sold 100 shares at an average price of 11.62 yuan, leaving him with 1.9209 million shares [1] - Other notable transactions include a significant sale by Ma Jianjian of 630,000 shares on June 26, 2023, at an average price of 9.5 yuan [1] Market Capitalization - The total market capitalization of Innovation Medical is reported to be 4.911 billion yuan [1]